International Clinical Trial: A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2031250283) titled 'A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata' on Aug. 5.

Study Type: Interventional

Study Design: randomized controlled trial, double blind, placebo control, parallel assignment, treatment purpose

Primary Sponsor: Kawai Norisuke

Condition: Severe Alopecia Areata

Intervention: *Drug: Ritlecitinib higher dose -Study intervention will be provided as oral capsules centrally by the sponsor in high-density polyethylene (HDPE) bottles. -Other Names: #Active Treatment *Drug: Ritlecitinib lower dose -Study intervention will be provided as ...